Commission Decision of 31 October 2008 setting a new deadline for the submission of dossiers for certain substances to be examined under the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC (notified under document number C(2008) 6266) (Text with EEA relevance) (2008/831/EC)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/decision/2008/831@2008-10-31/en
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market, and in particular the second subparagraph of Article 16(2) thereof,
Whereas:
(1) Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market establishes a list of active substances to be assessed, with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC.
(2) For a number of substances/product-type combinations included in that list, either all participants have withdrawn or no dossier has been received within the deadline specified in Article 9(2)(c) of Regulation (EC) No 1451/2007 by the Member State designated as rapporteur for the evaluation.
(3) Consequently, and pursuant to Article 11(2) of Regulation (EC) No 1451/2007, the Commission informed the Member States thereof. That information was also made public by electronic means on 8 November 2007.
(4) Within three months of the electronic publication of that information, companies indicated an interest in taking over the role of participant for some of the substances and product-types concerned, in accordance with Article 12(1) of Regulation (EC) No 1451/2007.
(5) A new deadline should therefore be established for the submission of dossiers for these substances and product-types in accordance with the second subparagraph of Article 12(3) of that Regulation.
(6) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Biocidal Products,
HAS ADOPTED THIS DECISION:
Article 1
For the substances and the product-types set out in the Annex, the new deadline for the submission of dossiers shall be 1 December 2009.
Article 2
This Decision is addressed to the Member States.
Done at Brussels, 31 October 2008. For the Commission Stavros Dimas Member of the Commission
ANNEX
ANNEX Substances and product-types for which the new deadline for the submission of dossiers is 1 December 2009
Name EC number CAS number Producttype RMS 1,2-benzisothiazol-3(2H)-one 220-120-9 2634-33-5 2 ES 2,2′-dithiobis[N-methylbenzamide] 219-768-5 2527-58-4 6 PL 2,2′-dithiobis[N-methylbenzamide] 219-768-5 2527-58-4 13 PL 2-Butanone, peroxide 215-661-2 1338-23-4 1 HU 2-Butanone, peroxide 215-661-2 1338-23-4 2 HU 2-Butanone, peroxide 215-661-2 1338-23-4 3 HU 2-Butanone, peroxide 215-661-2 1338-23-4 6 HU 2-chloroacetamide 201-174-2 79-07-2 3 EE 2-chloroacetamide 201-174-2 79-07-2 6 EE 2-chloroacetamide 201-174-2 79-07-2 13 EE Dodecylguanidine monohydrochloride 237-030-0 13590-97-1 6 ES Ethylene oxide 200-849-9 75-21-8 2 NO Glyoxal 203-474-9 107-22-2 2 FR Glyoxal 203-474-9 107-22-2 3 FR Glyoxal 203-474-9 107-22-2 4 FR Hexa-2,4-dienoic acid/Sorbic acid 203-768-7 110-44-1 6 DE Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol 255-953-7 42822-86-6 1 UK Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol 255-953-7 42822-86-6 2 UK Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) Polymer 374572-91-5 1 FR Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) Polymer 374572-91-5 5 FR Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) Polymer 374572-91-5 6 FR Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) Polymer 374572-91-5 13 FR Poly(hexamethylendiamine guanidinium chloride) Polymer 57028-96-3 1 FR Poly(hexamethylendiamine guanidinium chloride) Polymer 57028-96-3 5 FR Poly(hexamethylendiamine guanidinium chloride) Polymer 57028-96-3 6 FR Poly(hexamethylendiamine guanidinium chloride) Polymer 57028-96-3 13 FR Polyvinylpyrrolidone iodine Polymer 25655-41-8 1 SE Potassium (E,E)-hexa-2,4-dienoate 246-376-1 24634-61-5 6 DE Pyridine-2-thiol 1-oxide, sodium salt 223-296-5 3811-73-2 2 SE Pyridine-2-thiol 1-oxide, sodium salt 223-296-5 3811-73-2 3 SE Salicylic acid 200-712-3 69-72-7 1 LT Salicylic acid 200-712-3 69-72-7 2 LT Salicylic acid 200-712-3 69-72-7 3 LT Salicylic acid 200-712-3 69-72-7 4 LT Silicon dioxide — amorphous 231-545-4 7631-86-9 3 FR Silver chloride 232-033-3 7783-90-6 3 SE Silver chloride 232-033-3 7783-90-6 4 SE Silver chloride 232-033-3 7783-90-6 5 SE Silver chloride 232-033-3 7783-90-6 13 SE Sulphur dioxide 231-195-2 7446-09-5 1 DE Sulphur dioxide 231-195-2 7446-09-5 2 DE Sulphur dioxide 231-195-2 7446-09-5 4 DE Sulphur dioxide 231-195-2 7446-09-5 5 DE Sulphur dioxide 231-195-2 7446-09-5 6 DE Sulphur dioxide 231-195-2 7446-09-5 13 DE Thiabendazole 205-725-8 148-79-8 2 ES Thiabendazole 205-725-8 148-79-8 13 ES Triclosan 222-182-2 3380-34-5 3 DK Polymer of formaldehyde and acrolein Polymer 26781-23-7 3 HU